Omnicare Gets FCA Off-Label Prescription Action Trimmed

Law360, New York (May 20, 2013, 2:32 PM EDT) -- A Georgia federal judge on Friday trimmed several claims from a False Claims Act suit accusing Omnicare Inc. of charging Medicare for thousands of anti-psychotic drug prescriptions for off-label uses, ruling they weren't backed by evidence or were improperly added to an amended complaint.

According to U.S. District Judge William S. Duffey Jr., a “reverse” false claim allegation of relator Fox Rx Inc. —  a sponsor of Medicare Part D prescription drug plans — wasn’t authorized to be added to an amended complaint, and several of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

United States of America, ex rel. et al v. Omnicare, Inc. et al


Case Number

1:11-cv-00962

Court

Georgia Northern

Nature of Suit

Fraud or Truth-In-Lending

Judge

William S. Duffey, Jr

Date Filed

March 25, 2011

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.